Crila® capsule is formulated from bioactive alkaloids extracted from Crinum latifolium L. var. crilae Tram & Khanh which is a novel variety of Crinum latifolium species in Vietnam with a completed technological process. The alkaloids which have been selected are almost free of side effects and harmless to the public health.
CRILA is for the treatment of Uterine fibroids in women and Benign prostatic hyperplasia (BPH) in men, reducing symptoms of BPH (urinary difficulty, lots of urinations at night).
Crila is the first capsule for uterine fibroids in the world and is one of three capsule for the treatment of benign prostatic hypertrophy manufactured from Vietnamese Crinum latifolium L.
Materials for manufacturing Crila are harvested from the first GACP-WHO (Good Agriculture and Collection Practice - World Health Organization) certified plantation in Vietnam. Source of medicinal materials is clean, stable in bioactivity, correctly identified in terms of chemical composition and botany, required bioactive content, formulated and extracted at the GMP-WHO manufacturing factory of Thien DuocPharma JSC.
The prize that Crila has won:
|Crila capsule - Gold medal at the fair of international and oriental medicine in 2006
|Crila capsule - Gold icon for the community health care industry
|CRILA won Vietnam Gold Star Award 2013
|CRILA won Vietnam Excellent Medicine Prize for the first time
|CRILA won Vietnam Gold Star Award 2015
Crila® capsule is one of the national medicinal products to be chosen for investment in research and development, serving the people's health and export.
- Treatment of the benign prostatic hyperplasia. Reduction systems of benign prostatic hyperplasia disease (urinary difficulty, lots of urinations at night)
- Treatment of the fibroid uterus.
Contra indication: Susceptibility one of medicine composition.
Composition: Each capsule contains
Dried extract of Crinum latifolium L. 250mg, equivalent to 1.25mg total alkaloids.
Excipients: Starch, Aerosil, Sodium starch glycolate, Talc, magnesium stearate…q.s capsule
Pharmaceutical form: Capsule
Treatment of the benign prostatic hyperplasia: Take 4 capsules, two times daily, after meals. Usual use Crila is 8 weeks. If necessary, use Crila capsules another time again
Treatment of the fibroid uterus: Take 5 capsules, two times daily, after meals. Usual use Crila is 9 weeks. If necessary, use Crila capsules another time again
* No use medicine after the expiry date or in case of doubt medicine quality.
Packaging: A box of 4 bottle x 40 capsules.
A box of blisters x 10 capsules.
Undesirable effects: Slight dizziness, indigestion may occur, but rare case and without occurrence after taking medicine one, two days
Interation: Not reported yet
Storage: Keep in dry cool place, protected from sunlight
Shelf-life: 24 months from manufacturing date.
Read carefully directions before use.
For further information, please ask your doctor. Keep out of the reach of the children.
Inform your doctor if undesirable effects occur when using this product